Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting

Key Takeaway: Coya Therapeutics is set to present the design of its ALSTARS trial at the upcoming ENCALS 2026 Meeting. This presentation aims to share insights into the trial's structure and objectives, contributing to the ongoing discussions in the field of ALS research.